Post by nita on Jan 27, 2021 8:16:50 GMT
The global genomics market size is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.
For more information in the analysis of this report, visit: www.fortunebusinessinsights.com/industry-reports/genomics-market-100941
Some of the other leading players operating in the global market are:
Thermo Fisher Scientific Inc.
Oxford Nanopore Technologies
Danaher
QIAGEN
BGI
IntegraGen
The genomics market report outlines the present and future scenario of the market by offering key insights into the trends and drivers stimulating growth. Furthermore, it highlights detailed information on several aspects of the market which include opportunities, challenges, and threats. The report throws lights on the competitive landscape by covering key developments of some of the leading players. It also highlights strategies adopted by players, which in turn, can help stakeholders to make business decisions. Further to this, it also showcases information on all the major segments and their respective market share.
Advancements in Bioinformatics to Boost the Market in North America
Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.
Start-ups to Focus on Providing Genomics Services to Customers
Veritas Genomics announced the launch of new genome sequencing products in November 2018. The company aims to enhance its customer service and expand its product portfolio. Other companies such as Agilent Technologies, Inc., Illumina, Inc., and F. Hoffmann-La Roche Ltd are expected to lead the market in the forecast period. This is mainly on account of their strong product portfolio and wide geographical reach
For more information in the analysis of this report, visit: www.fortunebusinessinsights.com/industry-reports/genomics-market-100941
Some of the other leading players operating in the global market are:
Thermo Fisher Scientific Inc.
Oxford Nanopore Technologies
Danaher
QIAGEN
BGI
IntegraGen
The genomics market report outlines the present and future scenario of the market by offering key insights into the trends and drivers stimulating growth. Furthermore, it highlights detailed information on several aspects of the market which include opportunities, challenges, and threats. The report throws lights on the competitive landscape by covering key developments of some of the leading players. It also highlights strategies adopted by players, which in turn, can help stakeholders to make business decisions. Further to this, it also showcases information on all the major segments and their respective market share.
Advancements in Bioinformatics to Boost the Market in North America
Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.
Start-ups to Focus on Providing Genomics Services to Customers
Veritas Genomics announced the launch of new genome sequencing products in November 2018. The company aims to enhance its customer service and expand its product portfolio. Other companies such as Agilent Technologies, Inc., Illumina, Inc., and F. Hoffmann-La Roche Ltd are expected to lead the market in the forecast period. This is mainly on account of their strong product portfolio and wide geographical reach